Neonatal diabetes -: The role of KCNJ11 (Kir6.2)

被引：0

作者：

Tammaro, Paolo ^{[1
]}

机构：

[1] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England

来源：

CONGENITAL ENDOCRINOPATHIES: NEW INSIGHTS INTO ENDOCRINE DISEASES AND DIABETES | 2007年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ATP-sensitive potassium (K-ATP) channels are inhibited by intracellular ATP and activated by MgADP. As a consequence, they couple the metabolic state of the cell to its electrical activity. In pancreatic P-cells KATp channels regulate glucose-dependent insulin secretion and are the target for sulphonylurea drugs clinically employed in the treatment of type 2 diabetes. This review discusses recent advances in our understanding of the role of KATp channels in permanent neonatal diabetes mellitus. Copyright (C) 2007 S. Karger AG, Basel.

引用

页码：70 / 82

页数：13

共 50 条

[31] An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide
Eman M. Sherif
Abeer A. Abdelmaksoud
Nancy S. Elbarbary
Pål Rasmus Njølstad
Acta Diabetologica, 2013, 50 : 801 - 805
[32] Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype
Flanagan, SE
Edghill, EL
Gloyn, AL
Ellard, S
Hattersley, AT
DIABETOLOGIA, 2006, 49 (06) : 1190 - 1197
[33] Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype
S. E. Flanagan
E. L. Edghill
A. L. Gloyn
S. Ellard
A. T. Hattersley
Diabetologia, 2006, 49 : 1190 - 1197
[34] Effects of a Diet Supplemented with Fruit Antioxidants (Mango) on the Expression of Kir6.2 (KCNJ11) in the Hippocampus and Kidney of Diabetic Rats
D. P. Romo-Robles
J. A. Domínguez-Avila
M. Montiel-Herrera
J. F. Ayala-Zavala
H. Astiazaran-Garcia
G. A. González-Aguilar
Neurophysiology, 2020, 52 : 430 - 437
[35] Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects (vol 55, pg 1705, 2006)
Shimomura, K.
Girard, C. A. J.
Proks, P.
Nazim, J.
Lippiat, J. D.
Cerutti, F.
Lorini, R.
Ellard, S.
Hattersley, A. T.
Barbetti, F.
Ashcroft, F. M.
DIABETES, 2007, 56 (03) : 897 - 897
[36] Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
G. Tonini
C. Bizzarri
R. Bonfanti
M. Vanelli
F. Cerutti
E. Faleschini
F. Meschi
F. Prisco
E. Ciacco
M. Cappa
C. Torelli
V. Cauvin
S. Tumini
D. Iafusco
F. Barbetti
Diabetologia, 2006, 49 : 2210 - 2213
[37] Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
Tonini, G.
Bizzarri, C.
Bonfanti, R.
Vanelli, M.
Cerutti, F.
Faleschini, E.
Meschi, F.
Prisco, F.
Ciacco, E.
Cappa, M.
Torelli, C.
Cauvin, V.
Tumini, S.
Iafusco, D.
Barbetti, F.
DIABETOLOGIA, 2006, 49 (09) : 2210 - 2213
[38] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2—initial and long-term response to sulfonylurea therapy
Verena M. Wagner
Britta Kremke
Olaf Hiort
Sarah E. Flanagan
Ewan R. Pearson
European Journal of Pediatrics, 2009, 168 : 359 - 361
[39] Psychiatric morbidity in children with KCNJ11 neonatal diabetes
Bowman, P.
Broadbridge, E.
Knight, B. A.
Pettit, L.
Flanagan, S. E.
Reville, M.
Tonks, J.
Shepherd, M. H.
Ford, T. J.
Hattersley, A. T.
DIABETIC MEDICINE, 2016, 33 (10) : 1387 - 1391
[40] Transient Neonatal Diabetes due to Kcnj11 Mutation
Kochar, I. P. S.
Kulkarni, K. P.
INDIAN PEDIATRICS, 2010, 47 (04) : 359 - 360

← 1 2 3 4 5 →